Literature DB >> 4895336

Fenfluramine (Ponderax) in the treatment of obese psychiatric out-patients.

R Gaind.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1969        PMID： 4895336     DOI： 10.1192/bjp.115.525.963

Source DB:  PubMed          Journal:  Br J Psychiatry        ISSN： 0007-1250            Impact factor:   9.319


× No keyword cloud information.
  4 in total

Review 1.  Drugs and depression.

Authors:  F A Whitlock; L E Evans
Journal:  Drugs       Date:  1978-01       Impact factor: 9.546

2.  EEG profiles of fenfluramine, amobarbital and dextroamphetamine in normal volunteers.

Authors:  M Fink; D M Shapiro; T M Itil
Journal:  Psychopharmacologia       Date:  1971

Review 3.  Fenfluramine: a review of its pharmacological properties and therapeutic efficacy in obesity.

Authors:  R M Pinder; R N Brogden; P R Sawyer; T M Speight; G S Avery
Journal:  Drugs       Date:  1975       Impact factor: 9.546

4.  Fenfluramine in the treatment of hypertensive patients with refractory obesity.

Authors:  M E Scott; P G Nelson
Journal:  Ulster Med J       Date:  1975
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.